Clinical Trial Update: Palbociclib, Trastuzumab,Pyrotinib and Fulvestrant Treatment in Patients With Brain Metastasis From ER/PR Positive, HER-2 Positive Breast Cancer: A Multi-center, Prospective Study in China [Phase 2]

View source ↗

Summary

A multi-center Phase 2 trial in China evaluating palbociclib, trastuzumab, pyrotinib, and fulvestrant for ER/PR-positive, HER2-positive breast cancer with brain…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer with Brain Metastases

Drugs mentioned

• Fulvestrant (fulvestrant)
• Palbociclib (palbociclib)
• Pyrotinib (pyrotinib)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Breast Cancer, Brain Metastases | Phase 2 | Status: UNKNOWN